جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

5 مُخرَج نتائج البحث عن «Gout»

مقالوصول مغلق202414استشهاد· Semantic Scholar

Simultaneous Estimation of Lesinurad and Allopurinol in the New FDA-Approved Products Using a Greener Normal-Phase HPTLC Method: Greenness Assessment Using the NEMI, Analytical Eco-Score, ChlorTox, and AGREE Methods

ACS Sustainable Chemistry & Engineering · مجلد 12 (4) · 1526-1535

Recently, the U.S. Food and Drug Administration (FDA) approved combined dosage forms of lesinurad (LND) and allopurinol (ALU) in fixed-dose combinations to treat hyperuricemia associated with gout. For the simultaneous estimation (SME) of LND and ALU, neither conventional “high-performance thin-layer chromatography (HPTLC)” nor a greener HPTLC approach has been published to date. This study was carried out to design and validate a rapid, sensitive, and greener normal-phase HPTLC technique for the SME of LND and ALU in FDA-approved fixed-dose combination tablets. Ethyl acetate, ethanol, and water in a ternary ratio of 70:20:10 (v/v/v) were employed as a greener eluent system for the SME of LND and ALU. Normal-phase silica gel 60F254S plates were employed as the stationary phase. At a wavelength of 240 nm, LND and ALU were simultaneously estimated. The current method’s greenness was assessed using the National Environmental Method Index (NEMI), Analytical Eco-Scale (AES), ChlorTox, and Analytical GREENness (AGREE) methodologies. The current method was linear in the 30–1200 ng/band range for LND and ALU. The current approach was extensively validated and demonstrated to be accurate, precise, robust, sensitive, and greener for the SME of LND and ALU. The results of all greenness tools, including NEMI, AES (89), ChlorTox (0.96 g), and AGREE (0.81) showed that the current approach had an exceptional greener profile. Using the present methodology, the amounts of LND in FDA-approved fixed-dose combinations A and B were measured to be 98.73 and 99.17%, respectively. Using the present methodology, the amounts of ALU in FDA-approved fixed-dose combinations A and B were determined to be 99.27 and 100.58%, respectively. These data support the applicability of the current methodology for SME of LND and ALU in FDA-approved products. The findings of this study suggested that the current approach may be consistently applied to measure the LND and ALU in FDA-approved products.

lesinuradallopurinolsimultaneous estimationfixed-dose combination tablets
مقالمفتوح (مستودع)20247استشهاد· Semantic Scholar

Ameliorative impacts of Sinapic acid against monosodium urate crystal-induced gouty arthritis and inflammation through different signaling pathways.

PubMed Central · مجلد 13 (4) · tfae130-tfae130

As known, gout a metabolic disease due to the urate crystals deposition in the joints and affect human health and state. Humans are looking for safe natural remedies from plants with safe, low cost and high effect on their health. Sinapic acid (SA) is found in plants and used as phytoconstituent in human diets. SA has strong antioxidant activity, bone-regenerative, anti-cancer, anti-allergic, and antidiabetic effects. The current study was outlined to confirm the anti-gout potential of SA against monosodium urate crystals (MSU)-induced gouty arthritis in mice. Positive gouty arthritis was conducted by administration of colchicine and MSU in the hind paw. SA was orally administered to negative and positive MSU arthritic mice at 25 and 50 mg/kg, one-hour before MSU injection (100 μg/kg intra-articular). At the end of the experiment, sampling was done for serum, histopathology, oxidative stress and gene expression analysis. The results showed that SA significantly recovered the joint edema and recovered MSU crystals-showed histopathological changes. The production of cytokines, leukocyte recruitment, oxidative stress, and nucleotide-binding domain, leucinerich-containing family, pyrin domain-containing-3 (NLRP3)-inflammasome genes expressions were increased in positive arthritic mice and ameliorated significantly by SA administration. Moreover, SA showed ameliorative impacts on air pouch model of mice as reported by the down regulation in the expression of inflammation related blood cells, proinflammatory cytokines and other transcriptional genes. In conclusion, sinapic acid showed a potential therapeutic use against side effects accompanying gouty arthritis and is good as a supplement against inflammation associated disorders.

sinapic acidgoutmonosodium urate crystalsNLRP3 inflammasome
مقالوصول مغلق2024

PREVALENCE OF HYPERURICEMIA AND GOUT AND THEIR RELATIONSHIP TO CERTAIN RISK FACTORS: A SYSTEMATIC REVIEW

Indian Journal Of Applied Research · 1-5

Background/ objectives: The frequency of related comorbidities, all-cause mortality, and societal costs are all on the rise, and so is the burden of gout and hyperuricemia globally. This systematic review aims to investigate the recently published literature on the prevalence and risk factors of gout and hyperuricemia. PubMed, Web of S Methods: cience, Science Direct, and Cochrane Library were systematically searched to include the relevant literature. Rayyan QRCI was used throughout this systematic approach. Results: Our results included eleven studies with a total of 204,759,079 patients diagnosed with gout and/ or hyperuricemia. The reported total prevalence of hyperuricemia was 40,169,245 (19.6%), and the prevalence of gout was 6,192,105 (3.02%). The included studies recorded a rising incidence of gout and hyperuricemia. Gout is thus an increasing problem over the world, and to addr Conclusion: ess and improve widespread poor care, international cooperation efforts are needed. Hyperuricemia and gout affected males more than females. Older age, obesity, male gender, less activity, a diet heavy in purines, and lower educational levels all had an impact on blood UA concentration. These are high-risk populations that need to have their UA levels regularly checked.

hyperuricemiagoutprevalencerisk factors
مقالمفتوح (مستودع)20227استشهاد· Semantic Scholar

Alternate Warm and Cold Therapy (AWCT) on Uricemia, Sleep, Pain, Functional Ability, and Quality of Life (USPFQoL) in Patients with Gout: A Path Forward

Journal of Healthcare Engineering · مجلد 2022 · 1-8

Objective. To understand the impact of alternate warm and cold therapy (AWCT) on uricemia, sleep, pain, functional ability, and quality of life in gout patients. Methods. A quasiexperimental, nonequivalent control group, pre and posttest design was adopted among 120 gout patients. The data were collected on demographics, comorbidities, pain level, joint swelling/joint tenderness, patient global assessment of response to treatment (PGART), health-related quality of life (HRQoL) with SF-36, sleep quality by Pittsburgh Sleep Quality Index (PSQI), and serum uric acid and assessed. Descriptive and inferential statistics were used to analyze the data. Results. Patients had mean age of 58 and 61 years, mean number of comorbidities was 1.8 and 1.4, as well as presence of arthritic comorbidities except gout was 1.1 and 0.8 among study and control group participants, respectively. Pain ( p < 0.001 ), PGART ( p = − 0.01 ), HRQoL, sleep quality, and level of SUA (mg/dl) improved significantly ( p < 0.01 ) among the study group over study periods. It affirms that the AWCT is effective in reducing pain, functional disability, and SUA, as well as improving the sleep quality and HRQoL of the gout patients. There was a reduced incidence of gout flares ( p < 0.001 ), and taking additional medicines for pain ( p < 0.01 ) was statistically significant among study participants. Except social functioning, other domains of health were significantly ( p < 0.05 ) affected by the comorbidities like hypertension, diabetes, heart disease, renal disease, and asthma/chronic obstructive pulmonary disease. Conclusions. Gout is independently associated with higher medical and arthritic comorbidity, and AWCT can be better and cost-effective alternative therapy for gout patients. In addition, it may lead to improved cardiac function, hypertension, and renal insufficiency.

goutserum uric aciduricemiasleep quality
مقالوصول مفتوح2021

Osteoarticular disorders in sickle cell disease

International Journal of Community Medicine and Public Health · مجلد 9 (1) · 513-513

Different organs can be affected secondary to sickle cell disease, including the central nervous system, kidneys, gastrointestinal tract, respiratory system, cardiovascular system, bone, and joints. This can lead to increased morbidity and mortality events among the affected patients. Osteoarticular complications represent a severe set of events for patients with sickle cell disease. These complications might include gouty, septic, juvenile, and erosive arthritis, dactylitis, bone infarction, and osteomyelitis. These are the most common complications reported in the literature, and some case reports even reported other types of complications that develop secondary to the previously mentioned ones. Adequate diagnosis might be challenging in some cases. Therefore, clinicians must be crucial in determining the appropriate clinical and radiographic manifestations. Treating these cases is also challenging. Consequently, clinicians should be aware of these complications to enhance the prognosis of the affected patients. Further research is needed for the standardization of the diagnostic and management approaches in these events.

sickle cell diseaseosteoarticular complicationsgoutseptic arthritis